A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer

Autor: Leighl, Natasha B., Burkes, Ronald L., Dancey, Janet E., Lopez, Pedro G., Higgins, Brian P., David Walde, P.L., Rudinskas, Leona C., Rahim, Yasmin H., Rodgers, Angela, Pond, Gregory R., Shepherd, Frances A.
Zdroj: In Clinical Lung Cancer September 2003 5(2):107-112
Databáze: ScienceDirect